MedTrace Logo

Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

NCT00334750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2021-02-02

No results posted yet for this study

Summary

This descriptive, non-interventional study will collect information on the presence of risk factors in newly diagnosed ocular hypertension and open-angle glaucoma patients in Canada.

Conditions

Interventions

OTHER

There is no intervention in this study.

This study is collecting information on the presence of risk factors in new diagnosed OH and OAG patients in Canada.

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00334750 on ClinicalTrials.gov